PCR

News on qPCR, digital PCR, amplification, point-of-care testing platforms in genetics, genomics, and molecular diagnostics.

Jul 7, 2022

MiRxes, Singapore Healthcare Organizations Partner to Develop Multi-Cancer Early Detection Test

May 24, 2022

Precipio Receives CE-IVD Mark for Hematologic Cancer Panels

May 17, 2022

Qiagen Gets CE Mark for Therascreen EGFR Plus RGQ Kit for Non-Small Cell Lung Cancer

Apr 26, 2022

Alercell to Distribute Zeesan Biotech Leukemia Fusion Gene Test Kit

Mar 31, 2022

New Esophageal Cancer Tests on Horizon as Hopkins Spinout Capsulomics Preps Clinical Launch
Premium

Mar 22, 2022

InnoSign Raises $8M in Series A Financing, Spins off From Royal Philips

Feb 23, 2022

Cerca Biotech Inks European Distribution Deals for MammaTyper Breast Cancer Subtyping Test

Feb 8, 2022

Biocartis, Ophiomics Partner to Commercialize Gene Expression Prognostic Test for Liver Cancer

Feb 4, 2022

Mainz Biomed Plans Study to Evaluate mRNA Biomarkers for Colorectal Cancer

Jan 5, 2022

DiaCarta to Explore XNA Clamp Tech for Low-Frequency Mutations Under NIH Collaboration

Jan 5, 2022

Nucleix Raises Additional $22M

Dec 9, 2021

Qiagen, Denovo Biopharma to Develop Liquid Biopsy CDx Test for Investigational Lymphoma Treatment

Nov 22, 2021

Cancer Dx Firms ACT Genomics, Sanomics Merge

Nov 2, 2021

Saga Diagnostics, AstraZeneca Ink Digital PCR Assay Development Deal

Aug 19, 2021

Amoy Diagnostics, Amgen Partner on Lung Cancer CDx Development for Lumakras in Japan

Aug 17, 2021

Amoy Diagnostics CDx Gets Japanese Approval to ID NSCLC Patients Eligible for Tepmetko

Aug 5, 2021

Promega, Henlius to Develop Microsatellite Instability CDx for Cancer Drug

Jul 28, 2021

FDA Clears Promega Microsatellite Instability Test System

Jul 20, 2021

UK Group Validating Natera ctDNA Test to Guide Therapy for Post-Operative Bladder Cancer
Premium

Jun 30, 2021

AmoyDx PCR Panel Receives Japanese Approval as CDx for Non-Small Cell Lung Cancer Therapies